| Brett Michael Rath, MD | |
|
15950 Sw Millikan Way, Beaverton, OR 97006 | |
| (503) 646-0161 | |
| (503) 264-3745 |
| Full Name | Brett Michael Rath |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 44 Years |
| Location | 15950 Sw Millikan Way, Beaverton, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831280312 | NPI | - | NPPES |
| 073643 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD18890 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence St Vincent Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Portland Clinic | 8224942867 | 83 |
News Archive
An opinion piece by a legal scholar from the Johns Hopkins Berman Institute of Bioethics in this week's issue of Nature calls for the Food and Drug Administration to regulate all health-related genetic tests — whether available directly to consumers or through a health care provider — using an approach that imposes requirements proportionate to a test's level of risk.
A study published in the JAMA Otolaryngology-Head & Neck Surgery examines the effect of Medicaid expansion on head and neck cancer patients, finding that the expansions under the Affordable Care Act were associated with improved access to care for these patients and selective Medicaid expansion may worsen existing regional disparities in terms of access to care and outcomes.
Identifying ways to prevent dementia is a public health priority. Evidence suggests that aspirin and other anti-inflammatory drugs may protect against dementia, but data from randomised studies to date have been inconclusive.
Fetal development has been known to play an important role in social interaction, a fundamental behavior found in nearly all organisms, and later adult social behaviors. Autism, a highly heritable neurodevelopment disorder that causes difficulties with social interactions, has been postulated to be caused by neuron overgrowth in the prenatal period, although the precise timing and cause of this overgrowth has been unknown.
Peregrine Pharmaceuticals, Inc. today announced financial results for the second quarter of fiscal year (FY) 2010 ended October 31, 2009. Total revenue for the second quarter of FY 2010 increased 255% to $6,896,000, compared to $1,941,000 for the comparable prior year quarter.
› Verified 8 days ago
| Entity Name | Portland Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558379099 PECOS PAC ID: 8224942867 Enrollment ID: O20031118000101 |
News Archive
An opinion piece by a legal scholar from the Johns Hopkins Berman Institute of Bioethics in this week's issue of Nature calls for the Food and Drug Administration to regulate all health-related genetic tests — whether available directly to consumers or through a health care provider — using an approach that imposes requirements proportionate to a test's level of risk.
A study published in the JAMA Otolaryngology-Head & Neck Surgery examines the effect of Medicaid expansion on head and neck cancer patients, finding that the expansions under the Affordable Care Act were associated with improved access to care for these patients and selective Medicaid expansion may worsen existing regional disparities in terms of access to care and outcomes.
Identifying ways to prevent dementia is a public health priority. Evidence suggests that aspirin and other anti-inflammatory drugs may protect against dementia, but data from randomised studies to date have been inconclusive.
Fetal development has been known to play an important role in social interaction, a fundamental behavior found in nearly all organisms, and later adult social behaviors. Autism, a highly heritable neurodevelopment disorder that causes difficulties with social interactions, has been postulated to be caused by neuron overgrowth in the prenatal period, although the precise timing and cause of this overgrowth has been unknown.
Peregrine Pharmaceuticals, Inc. today announced financial results for the second quarter of fiscal year (FY) 2010 ended October 31, 2009. Total revenue for the second quarter of FY 2010 increased 255% to $6,896,000, compared to $1,941,000 for the comparable prior year quarter.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brett Michael Rath, MD 800 Sw 13th Ave, Portland, OR 97205-1902 Ph: (503) 221-0161 | Brett Michael Rath, MD 15950 Sw Millikan Way, Beaverton, OR 97006 Ph: (503) 646-0161 |
News Archive
An opinion piece by a legal scholar from the Johns Hopkins Berman Institute of Bioethics in this week's issue of Nature calls for the Food and Drug Administration to regulate all health-related genetic tests — whether available directly to consumers or through a health care provider — using an approach that imposes requirements proportionate to a test's level of risk.
A study published in the JAMA Otolaryngology-Head & Neck Surgery examines the effect of Medicaid expansion on head and neck cancer patients, finding that the expansions under the Affordable Care Act were associated with improved access to care for these patients and selective Medicaid expansion may worsen existing regional disparities in terms of access to care and outcomes.
Identifying ways to prevent dementia is a public health priority. Evidence suggests that aspirin and other anti-inflammatory drugs may protect against dementia, but data from randomised studies to date have been inconclusive.
Fetal development has been known to play an important role in social interaction, a fundamental behavior found in nearly all organisms, and later adult social behaviors. Autism, a highly heritable neurodevelopment disorder that causes difficulties with social interactions, has been postulated to be caused by neuron overgrowth in the prenatal period, although the precise timing and cause of this overgrowth has been unknown.
Peregrine Pharmaceuticals, Inc. today announced financial results for the second quarter of fiscal year (FY) 2010 ended October 31, 2009. Total revenue for the second quarter of FY 2010 increased 255% to $6,896,000, compared to $1,941,000 for the comparable prior year quarter.
› Verified 8 days ago
Philip W Pritchard, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1881 Nw 185th Ave, Suite 300, Beaverton, OR 97006 Phone: 503-216-9300 Fax: 503-216-9339 | |
David Albert Pierce, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 15950 Sw Millikan Way, Beaverton, OR 97006 Phone: 503-646-0161 Fax: 503-221-4451 | |
Dr. Carolyn Lee Goebel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2935 Sw Cedar Hills Blvd, Beaverton, OR 97005 Phone: 503-352-6000 | |
Dr. Gerald Wendal Miller, M.D, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1960 Nw 167th Place, Suite 103, Beaverton, OR 97006 Phone: 503-466-1823 Fax: 503-466-1823 | |
Dr. Priscilla Butler, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4855 Sw Western Ave, Beaverton, OR 97005 Phone: 503-643-7565 | |
Vicki Lynne Reid, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4855 Sw Western Ave, Beaverton, OR 97005 Phone: 503-520-4863 | |
Vanessa H Mckiel, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2935 Sw Cedar Hills Blvd, Beaverton, OR 97005 Phone: 503-352-6000 |